← Back to catalogue

Methadone Metabolite 100 Control Set

FDA UDI

Class I (US FDA UDI)

by Lin-Zhi International, Inc.

Identity

Trade Name
Methadone Metabolite 100 Control Set FDA UDI
Generic Name
2-ethylidine-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) IVD, control FDA UDI
Device Name
EDDP 100 Negative Control 75 ng/mL (2 x 15 mL), EDDP 100 Positive Control 125 ng/mL (2 x 15 mL). FDA UDI
Model / Reference
08735620190 FDA UDI
Description
EDDP 100 Negative Control 75 ng/mL (2 x 15 mL), EDDP 100 Positive Control 125 ng/mL (2 x 15 mL). FDA UDI

Identifiers

Catalog Number
08735620190 FDA UDI
Primary DI / UDI-DI
00850624008209 FDA UDI
FDA Product Code
LAS FDA UDI
GMDN Term
2-ethylidine-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) IVD, control FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.3280 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: 2-ethylidine-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) IVD, control

Methadone Metabolite 100 Control Set by Lin-Zhi International, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as 2-ethylidine-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) IVD, control.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 061b9374-7b46-4cc3-96b1-1c6d7d599eee 35 fields · synced Jun 9, 2026